Oncotelic Launches PR Chatbot
AGOURA HILLS, Calif., June 12, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We” or “Our”), annouces the beta unveiling of a pioneering press releases (“PR”) chatbot. This chatbot is set to redefine user interaction by providing interactive responses to all our press releases through April 24, 2023.
Related news for (OTLC)
- Product Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence
- ONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGY
- ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING
- ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING
- Linkage of Cancer and Lupus in Gliomas Patients